Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2025-12-28 @ 11:47 PM
Study NCT ID:
NCT04624906
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-17
First Post:
2020-10-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
Sponsor:
Sunnybrook Health Sciences Centre
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2030-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-23
First Submit QC Date:
None
Study First Post Date:
2020-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-14
Last Update Post Date:
2025-04-17
Last Update Post Date Type:
ACTUAL